Skip to main content
TipRanks
Go Ultimate75% OFF

Regencell Bioscience (RGC) Income Statement

628 Followers

Regencell Bioscience Income Statement

Last quarter (Q4 2026), Regencell Bioscience's total revenue was $0.00. In Q4, Regencell Bioscience's net income was $-6.38M. See Regencell Bioscience’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementJun 26Jun 25Jun 24Jun 23Jun 22
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ -404.54K$ -392.74K$ -745.59K$ -769.69K$ -604.40K
$ 11.32M$ 3.38M$ 3.99M$ 6.27M$ 7.62M
Depreciation and Amortization$ 404.54K$ 392.74K$ 745.59K$ 769.69K$ 604.40K
$ -11.32M$ -3.19M$ -3.62M$ -5.29M$ -6.99M
$ -11.72M$ -3.77M$ -4.74M$ -6.27M$ -7.62M
$ 22.52K$ 185.77K$ 373.50K$ 211.34K$ 23.21K
$ -11.70M$ -3.58M$ -4.36M$ -6.06M$ -7.59M
$ -11.70M$ -3.58M$ -4.30M$ -5.87M$ -7.42M
Per Share Metrics
Basic EPS$ -0.02$ -0.01$ -0.01$ -0.01$ -0.02
Diluted EPS$ -0.02$ -0.01$ -0.01$ -0.01$ -0.02
Weighted Average Shares Outstanding494.60M494.49M494.49M494.49M494.49M
Weighted Average Shares Outstanding (Diluted)494.60M494.49M494.49M494.49M494.49M

Currency in USD

Regencell Bioscience Earnings and Revenue History

-2B02B4B3.2 %4 %4.8 %5.6 %EarningsProfit Margin2017201820192020202120222023202420252026RevenueEarningsProfit Margin